Cyrano Therapeutics Patents – Insights & Stats (Updated 2023)

Cyrano Therapeutics has a total of 30 patents globally, out of which 13 have been granted. Of these 30 patents, more than 80% patents are active. United States of America is where Cyrano Therapeutics has filed the maximum number of patents, followed by Canada and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Cyrano Therapeutics.

Cyrano Therapeutics was founded in the year 2014. The Company is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell.

Do read about some of the most popular patents of Cyrano Therapeutics which have been covered by us in this article and also you can find Cyrano Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cyrano Therapeutics patent portfolio.

How many patents does the founder and the CEO of Cyrano Therapeutics have?

The founder Robert Henkin has 1 patent and CEO Rick Geoffrion has 0 patent.

How many patents does Cyrano Therapeutics have?

Cyrano Therapeutics has a total of 30 patents globally. These patents belong to 9 unique patent families. Out of 30 patents, 24 patents are active.

How Many Patents did Cyrano Therapeutics File Every Year?

Cyrano Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCyrano Therapeutics Applications FiledCyrano Therapeutics Patents Granted
202341
202231
202151
20202
201921
20183
201711
201521
201421
201322
201221

How many Cyrano Therapeutics patents are Alive/Dead?

Cyrano Therapeutics Patent Portfolio

How Many Patents did Cyrano Therapeutics File in Different Countries?

Cyrano Therapeutics Worldwide Patent Filing

Countries in which Cyrano Therapeutics Filed Patents

CountryPatents
United States Of America21
Canada1
Europe1
Hong Kong (S.A.R.)1

Where are Research Centres of Cyrano Therapeutics Patents Located?

The Research Centre for all the Cyrano Therapeutics patents is the United States of America.

10 Best Cyrano Therapeutics Patents

US8293489B2 is the most popular patent in the Cyrano Therapeutics portfolio. It has received 24 citations so far from companies like General Electric Company, Prometheus Biosciences Inc. and Immunaid Pty Ltd.

Below is the list of 10 most cited patents of Cyrano Therapeutics:

Publication NumberCitation Count
US8293489B224
US8663938B217
US20150297601A115
US8968706B214
US8506934B214
US8580801B212
US7670849B211
US20160030435A19
US20180143187A16
US9719988B25

List of Cyrano Therapeutics Patents

Cyrano Therapeutics PatentsTitle
US11774458B2Methods And Compositions For Diagnosing And Treating Loss And/Or Distortion Of Taste Or Smell
US11389453B2Compositions And Methods For Treating Chemosensory Dysfunction
US11125760B2Methods And Compositions For Diagnosing And Treating Loss And/Or Distortion Of Taste Or Smell
US10598672B2Methods And Compositions For Diagnosing And Treating Loss And/Or Distortion Of Taste Or Smell
US10555940B2Phosphodiesterase Inhibitor Treatment
US10206927B2Compostions And Methods For Treating Chemosensory Dysfunction
US9719988B2Methods For Detection Of Biological Substances
US8968706B2Methods For Diagnosing And Treating Loss Or Distortion Of Taste
US8663938B2Methods For Detection Of Biological Substances
US8580801B2Phosphodiesterase Inhibitor Treatment
US8506934B2Methods For Detection Of Biological Substances
US8293489B2Methods For Detection Of Biological Substances
US7670849B2Method For Diagnosing Insulin Resistance From Nasal Secretions
US20230147101A1Treatment Of Chemosensory Dysfunction From A Coronavirus Infection
US20220226332A1Phosphodiesterase Inhibitor Treatment
US20200375974A1Phosphodiesterase Inhibitor Treatment
EP4126233A1Treatment Of Chemosensory Dysfunction From A Coronavirus Infection
WO2023122473A3Gel Treatment For Loss Of Taste And Smell
WO2023122469A3Implants For Loss Of Taste And Smell
WO2023133459A1Nasal Spray For Phosphodiesterase Inhibitors
WO2023133460A1Improved Nasal Administration Of Pharmaceutical Formulations
WO2023133463A1Improved Nasal Administration Of Parkinson’S Therapeutics
CA3172275A1Treatment Of Chemosensory Dysfunction From A Coronavirus Infection
HK40084517ATreatment Of Chemosensory Dysfunction From A Coronavirus Infection
US20190231785A1Phosphodiesterase Inhibitor Treatment
US20190030036A1Phosphodiesterase Inhibitor Treatment
US20180143187A1Methods For Detection Of Biological Substances
US20160030435A1Phosphodiesterase Inhibitor Treatment
US20150297601A1Phosphodiesterase Inhibitor Treatment
WO2021194893A1Treatment Of Chemosensory Dysfunction From A Coronavirus Infection

What are Cyrano Therapeutics key innovation segments?

What Technologies are Covered by Cyrano Therapeutics?

The chart below distributes patents filed by Cyrano Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Cyrano Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Cyrano Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Cyrano Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.